Randomization
Participants were randomly assigned to receive a P2Y12 inhibitor or no P2Y12 inhibitor (usual care) in open-label fashion by a 1:1 ratio in permuted block sizes of 2 or 4 and stratified by site and severity of illness using a web-based system (eSOCDAT, Socar Research). Because of its fast onset with consistent and potent platelet inhibitory effects,